New patent for Intra-cellular drug CAPLYTA

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared f…


Which pharmaceutical drugs have the most drug patents in Israel?

This chart shows the drugs with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Israel? …


Biotechblog